BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 813327)

  • 1. Partial purification of factors XI and XIa: a comparison of their molecular size and structure.
    Connellan JM; Castaldi PA
    Thromb Res; 1975 Nov; 7(5):717-28. PubMed ID: 813327
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of factor XI and some properties of activated factor XI from porcine plasma.
    Mashiko H; Takahashi H
    Agents Actions Suppl; 1992; 38 ( Pt 2)():249-56. PubMed ID: 1462831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XI: purification from porcine plasma by affinity chromatography and some properties of factor XI and activated factor XI.
    Mashiko H; Takahashi H
    Biol Chem Hoppe Seyler; 1994 Jul; 375(7):481-4. PubMed ID: 7945997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit blood coagulation factor XI. Purification and properties.
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):475-86. PubMed ID: 494156
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).
    Fujikawa K; Legaz ME; Kato H; Davie EW
    Biochemistry; 1974 Oct; 13(22):4508-16. PubMed ID: 4473201
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of factor XI and sulfatide.
    Schiffman S; Rosenfeld R; Retzios AD
    Thromb Res; 1986 Feb; 41(4):575-80. PubMed ID: 3961736
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor XI: structure-function relationships utilizing monoclonal antibodies protein modification, computational chemistry, and rational synthetic peptide design.
    Walsh PN; Baglia FA; Jameson BA
    Methods Enzymol; 1993; 222():65-96. PubMed ID: 8412816
    [No Abstract]   [Full Text] [Related]  

  • 8. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.
    Bouma BN; Griffin JH
    J Biol Chem; 1977 Sep; 252(18):6432-7. PubMed ID: 893417
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact activation of factor XI.
    Jacobs A; Mannhalter C; Margalit R; Schiffman S
    Br J Haematol; 1981 Sep; 49(1):77-86. PubMed ID: 7272231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of platelet factor XI.
    Schiffman S; Yeh CH
    Thromb Res; 1990 Oct; 60(1):87-97. PubMed ID: 2278039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of corneal collagenases.
    Hook CW; Bull FG; Iwanij V; Brown SI
    Invest Ophthalmol; 1972 Sep; 11(9):728-34. PubMed ID: 4340862
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.
    Laake K; Venneröd AM
    Thromb Res; 1974 Feb; 4(2):285-302. PubMed ID: 4208626
    [No Abstract]   [Full Text] [Related]  

  • 14. Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavage.
    Villanueva GB; Leung L; Bradford H; Colman RW
    Biochem Biophys Res Commun; 1989 Jan; 158(1):72-9. PubMed ID: 2783551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIa-alpha 1 antitrypsin complex--elevation in the patients with DIC.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Nov; 44(4):489-501. PubMed ID: 3492061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and functional properties of factor XI and prekallikrein.
    Mannhalter CH
    Semin Thromb Hemost; 1987 Jan; 13(1):25-35. PubMed ID: 3551075
    [No Abstract]   [Full Text] [Related]  

  • 17. The activation of human factor IX.
    Osterud B; Laake K; Prydz H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):553-63. PubMed ID: 239460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact activation of factor XI: evidence that the primary role of contact activation cofactor (CAC) is to facilitate the activation of factor XII.
    Schiffman S; Pecci R; Lee P
    Thromb Res; 1977 Feb; 10(2):319-23. PubMed ID: 850914
    [No Abstract]   [Full Text] [Related]  

  • 19. Stoichiometry of binding of high molecular weight kininogen to factor XI/XIa.
    Warn-Cramer BJ; Bajaj SP
    Biochem Biophys Res Commun; 1985 Dec; 133(2):417-22. PubMed ID: 3936495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.
    Forbes CD; Ratnoff OD
    J Lab Clin Med; 1972 Jan; 79(1):113-27. PubMed ID: 4257309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.